• European Insurance Forum details announced by Karina Corbett on Thursday, March 19, 2015 via Business & Leadership

    "The event has a line-up of over 40 speakers, including some of the world’s leading experts and commentators in their respective fields, who will examine and discuss the growing global challenges facing the re/insurance and captive industry and in particular its impact on managing risk.

    Among the speakers secured for the event is Dr Aubrey de Grey, chief science officer at SENS Research Foundation and Prof Ian Goldin, professor of globalisation and development and director of the Oxford Martin School at the University of Oxford."

  • A Long Interview with Aubrey de Grey on London Real by Reason on Monday, March 16, 2015 via Fight Aging!

    "Aubrey de Grey is a true frontiersman, daring to push out against what seems the most natural and unstoppable forces of nature - ageing. He's not just another voice though, he's a scientist and identifies ageing as a disease, one that can be cured with the right medicine. His work calls for serious scientific exploration of what causes tissue to age and to then find solutions to those components - what he calls the roadmap to defeat biological ageing. In fact, he believes that the first humans who will live to be 1,000 years old are already alive today!"

  • Silicon Valley Is Trying to Make Humans Immortal—and Finding Some Success by Betsy Isaacson on Thursday, March 5, 2015 via Newsweek

    "Peter Thiel, the billionaire co-founder of PayPal, plans to live to be 120. Compared with some other tech billionaires, he doesn’t seem particularly ambitious. Dmitry Itskov, the “godfather” of the Russian Internet, says his goal is to live to 10,000; Larry Ellison, co-founder of Oracle, finds the notion of accepting mortality “incomprehensible,” and Sergey Brin, co-founder of Google, hopes to someday “cure death.”

    These titans of tech aren’t being ridiculous, or even vainglorious; their quests are based on real, emerging science that could fundamentally change what we know about life and about death."

  • Are We Hunting Longevity In All The Wrong Places? by Steven Kotler on Wednesday, March 4, 2015 via Forbes

    "Death—that was so last century. Here in the early 21st, it’s all about life. More life. A lot more life.

    Right now, anti-aging medicine is booming. For certain, the size of the market is a little hard to determine, but most estimates put it close to $300 billion. And growing.

    Already, serious heavyweights like Google and Human Longevity Inc. (HLI)—the company founded by X Prize founder Peter Diamandis, stem-cell pioneer Robert Hariri, and genomics visionary Craig Venter—have entered the fray. And, of course, ideas about slowing the insults of time are everywhere."

  • To These Foundations, Aging is the Enemy by Rick Docksai on Monday, February 23, 2015 via Inside Philanthropy

    "You already know that, as we grow older, we become more prone to many kinds of ailments: cancers, heart disease, dementia, and others. Any number of private foundations are sponsoring research targeting one or more of these age-related conditions. Less common, though, are foundations that are taking on the aging process itself.

    The Larry Ellison Medical Foundation used to be a leader in this area, but pulled the plug on such research in late 2013...

    But Ellison was never alone in his "war on death." And two funders still searching for a modern-day fountain of youth are the Methuselah Foundation and the SENS Research Foundation. Indeed, they are partnering on finding treatments that basically make older people young again. "

  • A Framework to Increase Longevity and End Aging by Damien Blenkinsopp on Friday, February 13, 2015 via The Quantified Body Podcast

    "Longevity is a subject close to my heart, and I’ve been following the career of today’s guest for many years. Dr. Aubrey de Grey is a visionary and general strategist in the field of gerontology who applies the concepts of planning, investment, and risk management to the science of aging. With his strategic approach, he’s created the seven “Strategies for Engineered Negligible Senescence” that offer a practical route to longer life.

    Dr. de Grey may be the greatest activist for longevity of our time. He’s the Chief Science Officer for the SENS Research Foundation, a not-for-profit organization funding research into longevity around the world. He’s authored two books; Ending Aging: The Rejuvenation Breakthroughs that Could Reverse Human Aging in our Lifetime in 2008 and The Mitochondrial Free-Radical Theory of Aging, for which he received his PhD in 1999.

    In today’s interview we examine popular longevity strategies such as caloric restriction and telomerase therapies, as well as those stemming from his research. His contrasting viewpoints offer insight compared to what you might see in the press."

  • SENS Research Foundation Now Accepts Bitcoin Donations by Reason on Monday, February 9, 2015 via Fight Aging!

    "SENS Research Foundation is one of the few organizations persistently finding ways to move the needle, to speed things up, to bring more attention to the field. The scope of success here is at present only limited by funding: there are any number of scientists in the aging research community who would drop their present work in favor of SENS biotechnology to treat aging given the budget.

    With that in mind, here is a little news for those who might have a few bitcoins left over after all the excitement of the past eighteen months or so..."

  • Living to 150 is the new holy grail on Saturday, January 31, 2015 via The Australian

    "Age defiance is a staggeringly lucrative ­industry. Last year the global anti-ageing ­market generated more than $280 billion. By 2018 it will hit $400 billion. A new tribe is ­taking advantage of sophisticated scientific breakthroughs... this appears to be only the beginning of the new age of ageing. It’s little wonder that the latest venture from Google, the most successful innovator on the planet, is ageing-related. Mere cosmetic enhancements are child’s play to Google, which is on an altogether more ambitious trajectory...

    Larry Ellison, CEO of the computer tech company Oracle and the fifth wealthiest man in the world, according to Forbes magazine, is the money behind the ­Ellison ­Medical Foundation, an anti-ageing biomedical research centre. The Californian venture capitalist Paul F. Glenn has endowed hundreds of ­millions to life-expansion research at Ivy League institutions such as Harvard, Princeton, MIT and Stanford. Peter Thiel, co-founder of PayPal and a Facebook board member, is a ­supporter of SENS, a research foundation ­specialising in rejuvenation treatments.

    SENS is run by Aubrey de Grey, a British ­gerontologist who believes that the first person to live to 150 is already alive today – a view shared by federal treasurer Joe Hockey, who was ridiculed recently for making this exact claim while arguing the case for budget cuts.

    “Rejuvenation biotechnologies are, very ­simply, medicines that restore the structure of the body to how it was in early adulthood, and thereby restore it to maximum physical and mental performance,” explains de Grey, who also co-founded the Methuselah – a foundation whose aim, through tissue engineering and regenerative medicine, is to create a world by 2030 in which 90-year-olds can be as healthy as 50-year-olds. “By restoring the molecular and cellular structure of the body to that of a young adult, we will necessarily restore its function, too, which constitutes reversing ageing. Thus, ­people will remain truly healthy for longer, postponing the ill health that inescapably accompanies old age today.”"

  • Exponential Medicine and Digital Healthcare by Nitish Kannan on Thursday, January 29, 2015 via h+ Magazine

    "Most people know that healthcare has rapidly become an information technology and health and medicine is changing exponentially.Just as technology is democratizing all aspects of life, no field is being disrupted more quickly than healthcare and the implications of digital will bring a trillion dollars worth of disruption to outdated diagnosis, treatment and delivery of healthcare. Moreover, the human race will live long enough soon to live forever as nanotechnology, robotics, Gene sequencing and AI cure age old problems."

    Interview with SRF CSO Dr. Aubrey de Grey, Dr. Dan Barry, and Vinod Khosla.

  • How to Best Hinder or Halt the Aging Process: A Roundtable Discussion on Regenerative Medicine on Monday, January 26, 2015 via Genetic Engineering and Biotechnology News

    Last month at the World Stem Cell Summit in San Antonio, TX, GEN’s editor-in-chief John Sterling moderated a panel discussion on “Regeneration Medicine: A New Era of Discovery and Innovation.” The following Q&A is based on some of the responses of several panel members.